AzTrials
AzTrials

Anesthesia Intubation ComplicationNCT01790646

Learning and Performance of Glidescope® Videolaryngoscope Intubation

An observational study of Anesthesia Intubation Complication, run by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta at 3 sites in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Glidescope laryngoscope was introduced as a novel tool for difficult intubation. Its learning curve was prooved on manikin but not in adult patients. Read more about this study

Who is it for?
Ages 16 to 85 yearsHealthy volunteers can take part
Conditions the study is for
Anesthesia Intubation Complication
What is being tested?
intubation
How many people
600 participants
Where
3 sitesItaly
Study dates
Sep 2012to May 2013
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: elective neurosurgical patients from a tertiary neurosurgical centre

Who may be able to join

  • any patient undergoing GA

Who cannot join

  • patients with predicted difficult intubation undergoing awake intubation

Trial locations and contacts

3 sites in 1 country.

Italy3 sites, 3 recruiting
  • Istituto Neurologico Besta

    Milan, 20136

    Paolo Cortellazzi, MD, +39022304 ext. 2420, paolo.cortellazzi@istituto-besta.it

    Paolo Cortellazzi, MD, +3902239 ext. 2420, paolo.cortellazzi@istituto-besta.it

    Recruiting
  • Istituto Neurologico Besta

    Milan, 20136

    Paolo Lamperti, MD, +39022394 ext. 2420

    Recruiting
  • Istituto Neurologico Besta

    Milan, 20136

    Massimo Lamperti, MD, +39022394 ext. 2420, paolo.cortellazzi@istituto-besta.it

    Paolo Cortellazzi, MD

    Recruiting

Other trials in Italy

About this study

Official title: Learning and Performance of Glidescope® Videolaryngoscope Intubation in Anesthesiologists Trained in Direct Laryngoscopy: a "in Vivo" Study

Glidescope laryngoscope was introduced as a novel tool for difficult intubation. Its learning curve was prooved on manikin but not in adult patients.

Read the detailed description

Glidescope® Videolaryngoscope is an angulated rigid optical device introduced in clinical practice in 2004 to facilitate endotracheal intubation.

Since its introduction potential benefits of this instrument might lie with use in patients with clinical features indicating difficult laryngoscopy or it being used as a rescue method following failed direct laryngoscopy. In a few centers was proposed and used routinely.

The performance of Glidescope® was studied in easy and difficult scenarios, in vivo and on manikins and compared with the reference standard McIntosh direct laryngoscopy. In patients with predicted or simulated difficult intubation, despite glottis visualization was improved with Glidescope®, the introduction of the tube in trachea was difficult the same as with McIntosh laryngoscopy. Training of operators before to entertain the trials varied from 20 to 50 Glidescope successful intubations. In an observational study Aziz et al. demonstrated in the two Institutions involved that the GlideScope® was used more frequently at the Institution were the failure rate was significantly lower. At this , 51 providers performed mean 21.7 GlideScope® intubations while at the other 91 providers performed 9.9 intubations.

These data highlight the important issue of how many Glidescope® intubations a provider should complete to reach a definitive clinical competence in this practice. Until now there is only one study performed on mankin comparing Glidescope® with AirTraq® and McIntosh laryngoscopes in novices . The authors concluded that despite a steep learning curve after 5 intubation difficulties in instrumentation and longer times to intubate persisted with Glidescope® in comparison with the other two devices. Outcome measures were: duration of intubation attempt, modified Cormack grades, dental trauma and difficulty of use.

In vivo both timely insertion of laryngoscope blade and introduction of the tube, no need of help or of external laryngeal displacement should be included to ascertain expertise with this new technology in patients with different grades of difficulty predicted.

Being tested
intubation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • intubationOther

    intubation using Glidescope videolaryngoscope

Study groups in NCT01790646
Study groupRoleWhat they receive
patients undergoing general anesthesiaevery elective patient undergoing general anesthesia for neurosurgical procedures with endotracheal intubation
Receives: Other: intubation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. number of attempts with Glidescope laryngoscopy necessary for beeing considered proficient

    from Glidescope blade insertion to succefull introduction of the tracheal tube and tube secured in the trachea with ETCO2 confirmation of tracheal ventilation

    Measured: from induction of GA to successful intubation

Secondary outcomes (1)
  1. Features useful to define a Glidescope intubation successful

    the following criteria have to be satisfied: one introduction of the laryngoscope, one introduction of the tube, Cormack-leane 1, no external laryngeal displacement, time to intubation <43 seconds, no need for help of an external operator, no complications

    Measured: successfull intubation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Feb 2013 (estimated)
  2. Study startSep 2012
  3. Primary completionMay 2013 (estimated)
  4. Study completionMay 2013 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01790646
Sponsor's protocol ID
INCCB 2012-02
Status last verified
Feb 2013
First submitted
8 Feb 2013
Last updated
13 Feb 2013
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Anesthesia Intubation Complication, run by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta at 3 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Feb 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Paolo Cortellazzi, MD (+39022394 ext. 2420, paolo.cortellazzi@istituto-besta.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

number of attempts with Glidescope laryngoscopy necessary for beeing considered proficient (time frame: from induction of GA to successful intubation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in